| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/JA0563455 |
| P698 | PubMed publication ID | 16492015 |
| P50 | author | Matthew P. Jacobson | Q42585539 |
| P2093 | author name string | Bin Yu | |
| Glenn L Millhauser | |||
| R Scott Lokey | |||
| Taha Rezai | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cyclo(L-leucyl-L-leucyl) | Q27135732 |
| P304 | page(s) | 2510-2511 | |
| P577 | publication date | 2006-03-01 | |
| P1433 | published in | Journal of the American Chemical Society | Q898902 |
| P1476 | title | Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers. | |
| P478 | volume | 128 |
| Q34318128 | A Cleavable Scaffold Strategy for the Synthesis of One-Bead One-Compound Cyclic Peptoid Libraries That Can Be Sequenced By Tandem Mass Spectrometry |
| Q30872676 | A bicyclic peptide scaffold promotes phosphotyrosine mimicry and cellular uptake |
| Q46481219 | A hydrogen bond surrogate approach for stabilization of short peptide sequences in alpha-helical conformation |
| Q50854229 | An In-tether Chiral Center Modulates the Helicity, Cell Permeability, and Target Binding Affinity of a Peptide. |
| Q58043817 | An atomistic model of passive membrane permeability: application to a series of FDA approved drugs |
| Q37418731 | Androgen receptor antagonism by divalent ethisterone conjugates in castrate-resistant prostate cancer cells |
| Q36016295 | Anthranilic acid-containing cyclic tetrapeptides: at the crossroads of conformational rigidity and synthetic accessibility |
| Q57065380 | Antibiotics from Deep-Sea Microorganisms: Current Discoveries and Perspectives |
| Q35168458 | Antimicrobial cyclic peptides for plant disease control |
| Q34445710 | Back to the future: can physical models of passive membrane permeability help reduce drug candidate attrition and move us beyond QSPR? |
| Q37532708 | Beyond cyclosporine A: conformation-dependent passive membrane permeabilities of cyclic peptide natural products. |
| Q48869308 | Biodistribution of the cyclotide MCoTI-II, a cyclic disulfide-rich peptide drug scaffold. |
| Q34480335 | Biomimetic diversity-oriented synthesis of benzannulated medium rings via ring expansion |
| Q54981966 | Bridged bicyclic peptides as potential drug scaffolds: synthesis, structure, protein binding and stability. |
| Q91646377 | CPProtectides: Rapid uptake of well-folded β-hairpin peptides with enhanced resistance to intracellular degradation |
| Q35859696 | Carbohydrates in diversity-oriented synthesis: challenges and opportunities |
| Q38436470 | Cell-Permeable Peptides Containing Cycloalanine Residues. |
| Q36393589 | Characterization of the macrocyclase involved in the biosynthesis of RiPP cyclic peptides in plants. |
| Q34680342 | Concise synthesis and biological assessment of (+)-neopeltolide and a 16-member stereoisomer library of 8,9-dehydroneopeltolide: identification of pharmacophoric elements |
| Q92347375 | Conformation of the Macrocyclic Drug Lorlatinib in Polar and Nonpolar Environments: A MD Simulation and NMR Study |
| Q57489617 | Conformational Sampling of Macrocyclic Drugs in Different Environments: Can We Find the Relevant Conformations? |
| Q49897525 | Consequences of Depsipeptide Substitution on the ClpP Activation Activity of Antibacterial Acyldepsipeptides |
| Q41916043 | Continuum approaches to understanding ion and peptide interactions with the membrane |
| Q59798384 | Cyclic Peptides: Promising Scaffolds for Biopharmaceuticals |
| Q38834152 | Cyclic peptide oral bioavailability: Lessons from the past. |
| Q35015231 | Cyclic peptides as therapeutic agents and biochemical tools |
| Q89386589 | Design and Development of a Cyclic Decapeptide Scaffold with Suitable Properties for Bioavailability and Oral Exposure |
| Q37106690 | Design of cyclic peptides that bind protein surfaces with antibody-like affinity |
| Q41108779 | Dimeric Macrocyclic Antagonists of Inhibitor of Apoptosis Proteins for the Treatment of Cancer |
| Q34271187 | Direct Ras Inhibitors Identified from a Structurally Rigidified Bicyclic Peptide Library |
| Q42936371 | EPSA: A Novel Supercritical Fluid Chromatography Technique Enabling the Design of Permeable Cyclic Peptides. |
| Q33824686 | Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery |
| Q47710705 | Effect of Stapling Architecture on Physiochemical Properties and Cell Permeability of Stapled α-Helical Peptides: A Comparative Study. |
| Q42116534 | Efficient delivery of cyclic peptides into mammalian cells with short sequence motifs |
| Q88611552 | Emerging Methods and Design Principles for Cell-Penetrant Peptides |
| Q33384451 | Encoded combinatorial libraries for the construction of cyclic peptoid microarrays |
| Q48362157 | Enhanced Permeability and Binding Activity of Isobutylene-Grafted Peptides. |
| Q107709506 | Ensemble completeness in conformer sampling: the case of small macrocycles |
| Q54563068 | Exocyclic control of turn induction in macrocyclic peptide scaffolds. |
| Q57080803 | Flexibility versus Rigidity for Orally Bioavailable Cyclic Hexapeptides |
| Q48250705 | From Peptides to Peptidomimetics: A Strategy Based on the Structural Features of Cyclopropane |
| Q27021652 | Getting in shape: controlling peptide bioactivity and bioavailability using conformational constraints |
| Q47324161 | Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase: Structure-Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)- |
| Q33336024 | High-throughput evaluation of relative cell permeability between peptoids and peptides |
| Q48203535 | Highly Conformationally Restricted Cyclopropane Tethers with Three-Dimensional Structural Diversity Drastically Enhance the Cell Permeability of Cyclic Peptides. |
| Q46269586 | Hydrophobic binding peptide-conjugated hybrid lipid-mesoporous silica nanoparticles for effective chemo-photothermal therapy of pancreatic cancer |
| Q57080817 | Improving on Nature: Making a Cyclic Heptapeptide Orally Bioavailable |
| Q47881312 | Interconversion Rates between Conformational States as Rationale for the Membrane Permeability of Cyclosporines |
| Q38031632 | Macrocycles in new drug discovery |
| Q39065925 | Macrocycles: lessons from the distant past, recent developments, and future directions |
| Q88822683 | Macrocyclic peptides: Tying up loose ends |
| Q97074341 | Methodologies for Backbone Macrocyclic Peptide Synthesis Compatible With Screening Technologies |
| Q49130565 | Microwave-assisted cleavage of Alloc and Allyl Ester protecting groups in solid phase peptide synthesis |
| Q40336836 | Microwave-assisted solid-phase synthesis of side-chain to side-chain lactam-bridge cyclic peptides |
| Q38982458 | Natural and Synthetic Macrocyclic Inhibitors of the Histone Deacetylase Enzymes |
| Q100750417 | Novel and potent antimicrobial effects of caspofungin on drug-resistant Candida and bacteria |
| Q34030237 | On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds |
| Q41515525 | Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearance(). |
| Q51052279 | Oxadiazole grafts in peptide macrocycles. |
| Q27703748 | Oxadiazole-Based Cell Permeable Macrocyclic Transition State Inhibitors of Norovirus 3CL Protease |
| Q39258096 | Oxidation of peptides by methyl(trifluoromethyl)dioxirane: the protecting group matters. |
| Q39619850 | Parallel synthesis of peptide-like macrocycles containing imidazole-4,5-dicarboxylic acid. |
| Q91782516 | Peptide Antiviral Strategies as an Alternative to Treat Lower Respiratory Viral Infections |
| Q42396570 | Peptide bicycles that inhibit the Grb2 SH2 domain |
| Q38895022 | Peptidyl-Proline Isomerases (PPIases): Targets for Natural Products and Natural Product-Inspired Compounds |
| Q39384465 | Predicting and improving the membrane permeability of peptidic small molecules. |
| Q101137933 | Predicting the Permeability of Macrocycles from Conformational Sampling - Limitations of Molecular Flexibility |
| Q90690810 | Prediction of Passive Membrane Permeability by Semi-Empirical Method Considering Viscous and Inertial Resistances and Different Rates of Conformational Change and Diffusion |
| Q35548736 | Principal component analysis as a tool for library design: a case study investigating natural products, brand-name drugs, natural product-like libraries, and drug-like libraries |
| Q38618616 | Rational, computer-enabled peptide drug design: principles, methods, applications and future directions. |
| Q39044453 | Restriction of the conformational dynamics of the cyclic acyldepsipeptide antibiotics improves their antibacterial activity |
| Q35620228 | Ribosomal Synthesis of Macrocyclic Peptides in Vitro and in Vivo Mediated by Genetically Encoded Aminothiol Unnatural Amino Acids |
| Q30490492 | Ring-Expansion Approach to Medium-Sized Lactams and Analysis of Their Medicinal Lead-Like Properties |
| Q33839863 | Ring-closing metathesis approaches for the solid-phase synthesis of cyclic peptoids |
| Q34832185 | Screening bicyclic peptide libraries for protein-protein interaction inhibitors: discovery of a tumor necrosis factor-α antagonist |
| Q41023966 | Selective Targeting of Cells via Bispecific Molecules That Exploit Coexpression of Two Intracellular Proteins |
| Q37008853 | Side-chain-to-tail cyclization of ribosomally derived peptides promoted by aryl and alkyl amino-functionalized unnatural amino acids |
| Q96954319 | Software-aided detection and structural characterization of cyclic peptide metabolites in biological matrix by high-resolution mass spectrometry |
| Q35563845 | Solid-phase synthesis of diverse peptide tertiary amides by reductive amination |
| Q36152470 | Strained cyclophane macrocycles: impact of progressive ring size reduction on synthesis and structure |
| Q38264736 | Strategic approaches to optimizing peptide ADME properties |
| Q34632423 | Synthesis and screening of stereochemically diverse combinatorial libraries of peptide tertiary amides |
| Q89220527 | Synthesis of Benzannulated Medium-ring Lactams via a Tandem Oxidative Dearomatization-Ring Expansion Reaction |
| Q35661360 | Synthesis of a large library of macrocyclic peptides containing multiple and diverse N-alkylated residues |
| Q51760697 | Synthesis of bicyclic organo-peptide hybrids via oxime/intein-mediated macrocyclization followed by disulfide bond formation. |
| Q28084617 | Synthesis of macrocyclic organo-peptide hybrids from ribosomal polypeptide precursors via CuAAC-/hydrazide-mediated cyclization |
| Q42844150 | Synthesis of peptide macrocycles using unprotected amino aldehydes |
| Q50023009 | Synthetic chloride transporters with the binding mode observed in a ClC chloride channel |
| Q36058900 | Testing physical models of passive membrane permeation |
| Q98192043 | The Critical Role of Passive Permeability in Designing Successful Drugs |
| Q64108951 | The Role of Toxins in the Pursuit for Novel Analgesics |
| Q37203934 | The exploration of macrocycles for drug discovery--an underexploited structural class |
| Q96639854 | Ultra-large chemical libraries for the discovery of high-affinity peptide binders |
| Q35764128 | cis-Peptide Bonds: A Key for Intestinal Permeability of Peptides? . |
| Q35025892 | mRNA display: from basic principles to macrocycle drug discovery |
Search more.